KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Operating Leases (2019 - 2025)

Exact Sciences has reported Operating Leases over the past 7 years, most recently at $161.9 million for Q4 2025.

  • Quarterly Operating Leases rose 3.03% to $161.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $161.9 million through Dec 2025, up 3.03% year-over-year, with the annual reading at $161.9 million for FY2025, 3.03% up from the prior year.
  • Operating Leases was $161.9 million for Q4 2025 at Exact Sciences, down from $163.9 million in the prior quarter.
  • Over five years, Operating Leases peaked at $210.8 million in Q4 2022 and troughed at $157.1 million in Q4 2024.
  • The 5-year median for Operating Leases is $182.8 million (2021), against an average of $180.8 million.
  • Year-over-year, Operating Leases skyrocketed 66.76% in 2021 and then dropped 20.66% in 2024.
  • A 5-year view of Operating Leases shows it stood at $201.9 million in 2021, then rose by 4.41% to $210.8 million in 2022, then fell by 9.68% to $190.4 million in 2023, then fell by 17.47% to $157.1 million in 2024, then rose by 3.03% to $161.9 million in 2025.
  • Per Business Quant, the three most recent readings for EXAS's Operating Leases are $161.9 million (Q4 2025), $163.9 million (Q3 2025), and $166.0 million (Q2 2025).